Nivalis Therapeutics Surrenders Early Gains

Loading...
Loading...

Nivalis Therapeutics Inc NVLS shares are trading higher by $0.02 at $2.26 in Tuesday's session.

The issue has been slow to recover from its beatdown on November 29. On that day, it declined from its previous close of $6.25 to $2.57 on the heels of a failed drug trial and multiple downgrades.

After a flat open, it rallied to $2.40 before backing off. That high coincides with its December 6 high ($2.37) and December 8 high ($2.38). At this time, the issue is attempting to find support at Friday's close ($2.26) as $2.21 stands as the current low for the day.

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...